Annelies Aerssens
Gent, VLG 9000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun® in last-minute travellers: an open-label, single-centre, randomized controlled pilot trial.
Journal: Journal of travel medicine
Published: February 21, 2023
Sanitary installations and wastewater plumbing as reservoir for the long-term circulation and transmission of carbapenemase producing Citrobacter freundii clones in a hospital setting.
Journal: Antimicrobial resistance and infection control
Published: January 20, 2023
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Journal: Lancet (London, England)
Published: October 16, 2020
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR.
Journal: BMC microbiology
Published: September 15, 2020
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination.
Journal: NPJ vaccines
Published: December 10, 2019
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 28, 2019
Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 20, 2018
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.
Journal: The Journal of infectious diseases
Published: August 15, 2017
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trial.
Journal: Vaccine
Published: July 19, 2017
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.
Journal: PloS one
Published: February 16, 2016
Last Updated: 09/26/2026